title: Changes of serum growth factors (IGF-I & IGFBP-2) and prediction of response to chemotherapy in patients with acute myeloid leukemia.
authors.affiliation: Department of Hematology, Medical Research Institute, Alexandria University, Alexandria, Egypt.
authors.forename: Amel A
authors.initials: AA
authors.lastname: El-Naggar
authors.forename: Bothaina F
authors.initials: BF
authors.lastname: Mahmoud
authors.forename: Lobna A
authors.initials: LA
authors.lastname: Abou Shamaa
authors.forename: Mona A
authors.initials: MA
authors.lastname: Salama
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003561:Cytarabine / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006801:Humans; D018971:Insulin-Like Growth Factor Binding Protein 2 / Q000097:blood*; D007334:Insulin-Like Growth Factor I / Q000032:analysis*; D015470:Leukemia, Myeloid, Acute / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011237:Predictive Value of Tests; D011379:Prognosis; D012074:Remission Induction; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D018971:Insulin-Like Growth Factor Binding Protein 2; D003561:Cytarabine; D007334:Insulin-Like Growth Factor I; D004317:Doxorubicin